If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Allan Lipton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
zoledronic acid Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Diphosphonates Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
pamidronate Medicine & Life Sciences
Aminoglutethimide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1969 2018

8 Citations (Scopus)

High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts

Lipton, A., Leitzel, K., Ali, S. M., Polimera, H. V., Nagabhairu, V., Marks, E., Richardson, A. E., Krecko, L., Ali, A., Koestler, W., Esteva, F. J., Leeming, D. J., Karsdal, M. A. & Willumsen, N., Dec 1 2018, In : International Journal of Cancer. 143, 11, p. 3027-3034 8 p.

Research output: Contribution to journalArticle

Extracellular Matrix
Breast Neoplasms
Collagen Type III
4 Citations (Scopus)

The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis

Gineyts, E., Bonnet, N., Bertholon, C., Millet, M., Pagnon-Minot, A., Borel, O., Geraci, S., Bonnelye, E., Croset, M., Suhail, A., Truica, C., Lamparella, N., Leitzel, K., Hartmann, D., Chapurlat, R., Lipton, A., Garnero, P., Ferrari, S., Clézardin, P. & Rousseau, J. C., Nov 1 2018, In : Calcified Tissue International. 103, 5, p. 567-580 14 p.

Research output: Contribution to journalArticle

Bone Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Bone and Bones
46 Citations (Scopus)

Continued treatment effect of zoledronic acid dosing every 12 vs 4 weeks in women with breast cancer metastatic to bone: The OPTIMIZE-2 randomized clinical trial

Hortobagyi, G. N., Van Poznak, C., Harker, W. G., Gradishar, W. J., Chew, H., Dakhil, S. R., Haley, B. B., Sauter, N., Mohanlal, R., Zheng, M. & Lipton, A., Jul 2017, In : JAMA Oncology. 3, 7, p. 906-912 7 p.

Research output: Contribution to journalArticle

zoledronic acid
Randomized Controlled Trials
Breast Neoplasms
Bone and Bones
3 Citations (Scopus)

Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)

Ho, D., Huang, J., Chapman, J. A. W., Leitzel, K., Ali, S. M., Shepherd, L., Parulekar, W. R., Ellis, C. E., Crescnzo, R. J., Zhu, L., Virk, S., Nomikos, D., Aparicio, S., Gelmon, K. A., Carney, W. P. & Lipton, A., Aug 1 2017, In : Breast Cancer Research and Treatment. 164, 3, p. 571-580 10 p.

Research output: Contribution to journalArticle

Tissue Inhibitor of Metalloproteinase-1
Breast Neoplasms
4 Citations (Scopus)

Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27

Lipton, A., Chapman, J. A. W., Leitzel, K., Garg, A., Pritchard, K. I., Ingle, J. N., Budd, G. T., Ellis, M. J., Sledge, G. W., Rabaglio, M., Han, L., Elliott, C. R., Shepherd, L. E., Goss, P. E. & Ali, S. M., Jul 1 2017, In : Cancer. 123, 13, p. 2444-2451 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival